Government driven model of institutional change through adoption of new technology: A case study of the failed pharmaceutical bidding and procurement platforms in China

Purpose - This paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e-bidding pl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese management studies 2012-01, Vol.6 (1), p.53-64
Hauptverfasser: Li, Mingzhi, Reimers, Kai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 64
container_issue 1
container_start_page 53
container_title Chinese management studies
container_volume 6
creator Li, Mingzhi
Reimers, Kai
description Purpose - This paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e-bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so-called "Chinese model" of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change. Design/methodology/approach - The analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers. Findings - The failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic. Originality/value - This paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.
doi_str_mv 10.1108/17506141211213726
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1019657059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1019657059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c230t-9e162b6f926c766b62b50a39a1f262d72cb73164610ed1a7f15fcb980388ffa73</originalsourceid><addsrcrecordid>eNplkEFLxDAUhHNQcF39Ad5y9FLNS7ZJe5RFV2FBEAVvJU1ftpU2WZN0Zf-9LetNeDC8mY85DCE3wO4AWHEPKmcSVsBhOqG4PCOL2csm8_OCXMb4xZjMJ2JB3jb-gMEN6BJtQndARwffYE-9pZ2LqUtj6rzTPTWtdjukqQ1-3LVUN34_JzPo8IcmNK3zvd8dr8i51X3E6z9dko-nx_f1c7Z93bysH7aZ4YKlrESQvJa25NIoKevpyZkWpQbLJW8UN7USIFcSGDaglYXcmrosmCgKa7USS3J76t0H_z1iTNXQRYN9rx36MVbAoJS5Ynk5oXBCTfAxBrTVPnSDDscJqubNqn-biV8HdGEs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1019657059</pqid></control><display><type>article</type><title>Government driven model of institutional change through adoption of new technology: A case study of the failed pharmaceutical bidding and procurement platforms in China</title><source>Emerald Journals</source><source>Standard: Emerald eJournal Premier Collection</source><creator>Li, Mingzhi ; Reimers, Kai</creator><contributor>Wei Wu, Wei</contributor><creatorcontrib>Li, Mingzhi ; Reimers, Kai ; Wei Wu, Wei</creatorcontrib><description>Purpose - This paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e-bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so-called "Chinese model" of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change. Design/methodology/approach - The analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers. Findings - The failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic. Originality/value - This paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.</description><identifier>ISSN: 1750-614X</identifier><identifier>DOI: 10.1108/17506141211213726</identifier><language>eng</language><subject>China ; Drugs ; Economics ; Electronics ; Governments ; Logic ; Pharmaceuticals ; Platforms</subject><ispartof>Chinese management studies, 2012-01, Vol.6 (1), p.53-64</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c230t-9e162b6f926c766b62b50a39a1f262d72cb73164610ed1a7f15fcb980388ffa73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,962,21676,27905,27906</link.rule.ids></links><search><contributor>Wei Wu, Wei</contributor><creatorcontrib>Li, Mingzhi</creatorcontrib><creatorcontrib>Reimers, Kai</creatorcontrib><title>Government driven model of institutional change through adoption of new technology: A case study of the failed pharmaceutical bidding and procurement platforms in China</title><title>Chinese management studies</title><description>Purpose - This paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e-bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so-called "Chinese model" of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change. Design/methodology/approach - The analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers. Findings - The failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic. Originality/value - This paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.</description><subject>China</subject><subject>Drugs</subject><subject>Economics</subject><subject>Electronics</subject><subject>Governments</subject><subject>Logic</subject><subject>Pharmaceuticals</subject><subject>Platforms</subject><issn>1750-614X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNplkEFLxDAUhHNQcF39Ad5y9FLNS7ZJe5RFV2FBEAVvJU1ftpU2WZN0Zf-9LetNeDC8mY85DCE3wO4AWHEPKmcSVsBhOqG4PCOL2csm8_OCXMb4xZjMJ2JB3jb-gMEN6BJtQndARwffYE-9pZ2LqUtj6rzTPTWtdjukqQ1-3LVUN34_JzPo8IcmNK3zvd8dr8i51X3E6z9dko-nx_f1c7Z93bysH7aZ4YKlrESQvJa25NIoKevpyZkWpQbLJW8UN7USIFcSGDaglYXcmrosmCgKa7USS3J76t0H_z1iTNXQRYN9rx36MVbAoJS5Ynk5oXBCTfAxBrTVPnSDDscJqubNqn-biV8HdGEs</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Li, Mingzhi</creator><creator>Reimers, Kai</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7TA</scope><scope>8FD</scope><scope>JG9</scope></search><sort><creationdate>20120101</creationdate><title>Government driven model of institutional change through adoption of new technology</title><author>Li, Mingzhi ; Reimers, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c230t-9e162b6f926c766b62b50a39a1f262d72cb73164610ed1a7f15fcb980388ffa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>China</topic><topic>Drugs</topic><topic>Economics</topic><topic>Electronics</topic><topic>Governments</topic><topic>Logic</topic><topic>Pharmaceuticals</topic><topic>Platforms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Mingzhi</creatorcontrib><creatorcontrib>Reimers, Kai</creatorcontrib><collection>CrossRef</collection><collection>Materials Business File</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><jtitle>Chinese management studies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Mingzhi</au><au>Reimers, Kai</au><au>Wei Wu, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Government driven model of institutional change through adoption of new technology: A case study of the failed pharmaceutical bidding and procurement platforms in China</atitle><jtitle>Chinese management studies</jtitle><date>2012-01-01</date><risdate>2012</risdate><volume>6</volume><issue>1</issue><spage>53</spage><epage>64</epage><pages>53-64</pages><issn>1750-614X</issn><abstract>Purpose - This paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e-bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so-called "Chinese model" of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change. Design/methodology/approach - The analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers. Findings - The failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic. Originality/value - This paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.</abstract><doi>10.1108/17506141211213726</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1750-614X
ispartof Chinese management studies, 2012-01, Vol.6 (1), p.53-64
issn 1750-614X
language eng
recordid cdi_proquest_miscellaneous_1019657059
source Emerald Journals; Standard: Emerald eJournal Premier Collection
subjects China
Drugs
Economics
Electronics
Governments
Logic
Pharmaceuticals
Platforms
title Government driven model of institutional change through adoption of new technology: A case study of the failed pharmaceutical bidding and procurement platforms in China
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A28%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Government%20driven%20model%20of%20institutional%20change%20through%20adoption%20of%20new%20technology:%20A%20case%20study%20of%20the%20failed%20pharmaceutical%20bidding%20and%20procurement%20platforms%20in%20China&rft.jtitle=Chinese%20management%20studies&rft.au=Li,%20Mingzhi&rft.date=2012-01-01&rft.volume=6&rft.issue=1&rft.spage=53&rft.epage=64&rft.pages=53-64&rft.issn=1750-614X&rft_id=info:doi/10.1108/17506141211213726&rft_dat=%3Cproquest_cross%3E1019657059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1019657059&rft_id=info:pmid/&rfr_iscdi=true